胃癌影响因素研究进展

doi:10.11904/j.issn.1002-3070.2020.05.015

摘要/Abstract

摘要： 胃癌一直以来都严重威胁着人类的健康生活。近年来已经对胃癌的影响因素进行了大量研究,且已经证实了幽门螺杆菌感染、抽烟、饮酒等因素在胃癌的发生发展过程中起着非常重要的作用,但影响胃癌发展形成的因素是多方面的。随着医疗技术的发展,我们对胃癌的认识不能仅局限于几个单方面因素。因此,本文介绍了胃癌的流行病学,同时回顾了过去研究中的新发现。

关键词: 胃癌, 流行病学, 危险因素

Abstract: Gastric cancer has always seriously threatened human health.In recent years,a large number of studies have been conducted on the influencing factors of gastric cancer,and it has been confirmed that Helicobacter pylori infection,smoking,drinking and other factors play a very important role in the occurrence and development of gastric cancer.With the development of medical technology,our understanding of gastric cancer cannot be limited to a few unilateral factors.Therefore,this article introduces the epidemiology of gastric cancer and reviews the new findings in the past studies.

Key words: Gastric cancer, Epidemiology, Risk factors

中图分类号:

R735.2

李健, 马麒, 任瑾, 呼圣娟. 胃癌影响因素研究进展[J]. 实用肿瘤学杂志, 2020, 34(5): 466-470.

LI Jian, MA Qi, REN Jin, HU Shengjuan. Research progress on influencing factors of gastric cancer[J]. Journal of Practical Oncology, 2020, 34(5): 466-470.

0
/ / 推荐

导出引用管理器 EndNote|Reference Manager|ProCite|BibTeX|RefWorks

链接本文: http://journal09.magtechjournal.com/Jwk3_syzlxzz/CN/10.11904/j.issn.1002-3070.2020.05.015

http://journal09.magtechjournal.com/Jwk3_syzlxzz/CN/Y2020/V34/I5/466

参考文献

1 Ferlay J,Soerjomataram I,Dikshit R,et al.Cancer incidence and mortality worldwide:sources,methods and major patterns in GLOBOCAN 2012[J].Int J Cancer,2015,136(5):359-386.
2 Chen W,Zheng R,Baade PD,et al.Cancer statistics in China,2015[J].CA Cancer J Clin,2016,66(2):115-132.
3 Fang X,Wei J,He X,et al.Landscape of dietary factors associated with risk of gastric cancer:a systematic review and dose-response meta-analysis of prospective cohort studies[J].Eur J Cancer,2015,51(18):2820-2832.
4 Bray F,Ferlay J,Soerjomataram I,et al.Global cancer statistics 2018:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2018,68(6):394-424.
5 周家琛,郑荣寿,庄贵华,等.2000-2015年中国肿瘤登记地区胃癌发病趋势及年龄变化[J].实用肿瘤学杂志,2020,34(1):1-5.
6 Kamangar F.Socio-economic health inequalities:ever-lasting facts or amenable to change?[J].Int J Prev Med,2013,4(6):621-623.
7 Jemal A,Bray F,Center MM,et al.Global cancer statistics[J].CA Cancer J Clin,2011,61(2):69-90.
8 Karimi P,Islami F,Anandasabapathy S,et al.Gastric cancer:descriptive epidemiology,risk factors,screening,and prevention[J].Cancer Epidemiol Biomarkers Prev,2014,23(5):700-713.
9 Epplein M,Signorello LB,Zheng W,et al.Race,African ancestry,and Helicobacter pylori infection in a low-income United States population[J].Cancer Epidemiol Biomarkers Prev 2011,20(5):826-834.
10 Brown LM,Devesa SS.Epidemiologic trends in esophageal and gastric cancer in the United States[J].Surg Oncol Clin N Am,2002,11(2):235-256.
11 Sanjeevaiah A,Cheedella N,Hester C.Gastric cancer:recent molecular classification advances,racial disparity,and management implications[J].J Oncol Pract,2018,14(4):217-224.
12 张茂祥,孙惠昕,宋冰冰.2008—2012年哈尔滨市道里区恶性肿瘤发病与死亡分析[J].实用肿瘤学杂志,2019,33(3):261-265.
13 Maehara Y,Kakeji Y,Koga T,et al.Therapeutic value of lymph node dissection and the clinical outcome for patients with gastric cancer[J].Surgery,2002,131(1):85-91.
14 杨之洵,郑荣寿,张思维,等.中国胃癌发病趋势及预测[J].中国肿瘤,2019,28(5):321-326.
15 Wang T,Cai H,Sasazuki S,et al.Fruit and vegetable consumption,helicobacter pylori antibodies,and gastric cancer risk:a pooled analysis of prospective studies in china,japan,and korea[J].Int J Cancer,2017,140(3):591-599.
16 Wang XQ,Yan H,Terry PD,et al.Interaction between dietary factors and Helicobacter pylori infection in noncardia gastric cancer:a population-based case-control study in China[J].J Am Coll Nutr,2012,31(5):375-384.
17 Sezikli M,Çetinkaya ZA,Güzelbulut F,et al.Effects of alpha tocopherol and ascorbic acid on Helicobacter pylori colonization and the severity of gastric inflammation[J].Helicobacter,2012,17(2):127-132.
18 Vingeliene S,Chan DS,Aune D,et al.An update of the WCRF/AICR systematic literature review on esophageal and gastric cancers and citrus fruits intake[J].Cancer Causes Control,2016,27(7):837-851.
19 Schwingshackl L,Schwedhelm C,Galbete C,et al.Adherence to mediterranean diet and risk of cancer:an updated systematic review and meta-analysis[J].Nutrients,2017,9(10):1063.
20 Song JH,Kim YS,Heo NJ,et al.High salt intake is associated with atrophic gastritis with intestinal metaplasia[J].Cancer Epidemiol Biomarkers Prev,2017,26(7):1133-1138.
21 Raei N,Behrouz B,Zahri S,et al.Helicobacter pylori infection and dietary Factors act synergistically to promote gastric cancer[J].Asian Pac J Cancer Prev,2016,17(3):917-921.
22 CKhasag O,Boldbaatar G,Tegshee T,et al.The prevalence of Helicobacter pylori infection and other risk factors among mongolian dyspeptic patients who have a high incidence and mortality rate of gastric cancer[J].Gut Pathog,2018,10:14.
23 Thapa S,Fischbach LA,Delongchamp R,et al.Association between Dietary Salt Intake and Progression in the Gastric Precancerous Process[J].Cancers(Basel),2019,11(4):467.
24 Baan R,Straif K,Grosse Y,et al.Carcinogenicity of alcoholic beverages[J].Lancet Oncol,2007,8(4):292-293.
25 Ferro A,Morais S,Rota M,et al.Alcohol intake and gastric cancer:Meta-analyses of published data versus individual participant data pooled analyses[J].Cancer Epidemiol,2018,54:125-132.
26 ANa HK,Lee JY.Molecular basis of alcohol-related gastric and colon cancer[J].Int J Mol Sci,2017,18(6):1116.
27 Maejima R,Iijima K,Kaihovaara P,et al.Effects of ALDH2 genotype,PPI treatment and l-cysteine on carcinogenic acetaldehyde in gastric juice and saliva after intragastric alcohol administration[J].PLoS One,2015,10:e0120397.
28 Tramacere I,Negri E,Pelucchi C,et al.A meta-analysis on alcohol drinking and gastric cancer risk[J].Ann Oncol,2012,23(1):28-36.
29 Bagnardi V,Rota M,Botteri E,et al.Alcohol consumption and site-specific cancer risk:a comprehensive dose-response meta-analysis[J].Br J Cancer,2015,112(3):580-593.
30 Ma K,Baloch Z,He TT,et al.Alcohol consumption and gastric cancer risk:a meta-analysis[J].Med Sci Monit,2017,23:238-246.
31 Kodali RT,Eslick GD.Meta-analysis:does garlic intake reduce risk of gastric cancer[J].Nutr Cancer,2015,67(1):1-11.
32 Turati F,Pelucchi C,Guercio V,et al.Allium vegetable intake and gastric cancer:a case-control study and meta-analysis[J].Mol Nutr Food Res,2015,59(1):171-179.
33 Kim H,Keum N,Giovannucci EL,et al.Garlic intake and gastric cancer risk:Results from two large prospective US cohort studies[J].Int J Cancer,2018,143(5):1047-1053.
34 De Assumpcão PP,Araújo TMT,De Assumpção PB,et al.Suicide journey of H.pylori through gastric carcinogenesis:the role of non-H.pylori microbiome and potential consequences for clinical practice[J].Eur J Clin Microbiol Infect Dis,2019,38(9):1591-1597.
35 Akiba S.Epstein-Barr virus associated gastric carcinoma:epidemiological and clinicopathological features[J].Cancer Sci,2008,99(2):195-201.
36 Huang SC.Prognostic factors in epstein-barr virus-associated stage I-III gastric carcinoma:implications for a unique type of carcinogenesis[J].Oncol Rep,2014,32(2):530-538.
37 Naseem M,Barzi A,Brezden-Masley C,et al.Outlooks on epstein-barr virus associated gastric cancer[J].Cancer Treat Rev,2018,66:15-22.
38 Janarthanan S,Ditah I,Adler DG,et al.Clostridium difficile-associated diarrhea and proton pump inhibitor therapy:a meta-analysis[J].Am J Gastroenterol,2012,107(7):1001-1010.
39 Forgacs I,Loganayagam A.Overprescribing proton pump inhibitors[J].BMJ,2008,336(7634):2-3.
40 Sherwood MW,Melloni C,Jones WS,et al.Individual proton pump inhibitors and outcomes in patients with coronary artery disease on dual antiplatelet therapy:a systematic review[J].J Am Heart Assoc,2015,4(11):e002245.
41 Lundell L,Vieth M,Gibson F,et al.Systematic review:the effects of long-term proton pump inhibitor use on serum gastrin levels and gastric histology[J].Aliment Pharmacol Ther,2015,42(6):649-663.
42 Cheung KS,Chan EW,Wong AYS,et al.Long-term proton pump inhibitors and risk of gastric cancer development after treatment for Helicobacter pylori:a population-based study[J].Gut,2018,67(1):28-35.
43 Magee L,Hale L.Longitudinal associations between sleep duration and subsequent weight gain:a systematic review[J].Sleep Med Rev,2012,16(3):231-241.
44 Gu F,Xiao Q,Chu LW,et al.Sleep duration and cancer in the NIH-AARP diet and health study cohort[J].PLoS One,2016,11(9):e0161561.
45 Malik SW,Kaplan J.Sleep deprivation[J].Prim Care,2005,32(2):475-490.
46 Tan P,Yeoh KG.Genetics and molecular pathogenesis of gastric adenocarcinoma[J].Gastroenterology,2015,149(5):1153-1162.
47 Figueiredo C,Machado JC,Pharoah P,et al.Helicobacter pylori and interleukin 1 genotyping:an opportunity to identify high-risk individuals for gastric carcinoma[J].J Natl Cancer Inst,2002,94(22):1680-1687.
48 Persson C,Canedo P,Machado JC,et al.Polymorphisms in inflammatory response genes and their association with gastric cancer:a HuGE systematic review and meta-analyses[J].Am J Epidemiol,2011,173(3):259-270.

[1]	尹松祥. Copine-8在胃癌组织中的表达与临床病理特征及预后的相关性[J]. 实用肿瘤学杂志, 2020, 34(5): 430-435.
[2]	石琳娜, 隋红. 早期胃癌淋巴结转移评估方法的研究现状[J]. 实用肿瘤学杂志, 2020, 34(3): 286-290.
[3]	周家琛, 郑荣寿, 庄贵华, 张思维, 曾红梅, 陈茹, 王少明, 孙可欣, 邹小农, 魏文强, 赫捷. 2000—2015年中国肿瘤登记地区胃癌发病趋势及年龄变化[J]. 实用肿瘤学杂志, 2020, 34(1): 1-5.
[4]	戴丹, 贾尚春, 陈叶纪, 贺琴, 查震球, 刘志荣. 安徽省肿瘤登记地区2015年胃癌发病与死亡[J]. 实用肿瘤学杂志, 2020, 34(1): 6-10.
[5]	王鸣, 孙梯业. PFKFB4对胃癌细胞侵袭和迁移能力的影响及其作用[J]. 实用肿瘤学杂志, 2020, 34(1): 37-42.
[6]	徐亭, 严斐斐, 张纯慧, 张艳桥. 胃癌骨转移患者临床病理与预后分析[J]. 实用肿瘤学杂志, 2019, 33(5): 436-441.
[7]	姚洋张艳桥. 胃癌免疫检查点抑制剂作用机制及最新研究进展[J]. 实用肿瘤学杂志, 2019, 33(4): 371-375.
[8]	秦文,赵楠楠,韩永焕,徐亚君. ZNF436在胃癌中的表达及调控WNT/β-catenin对胃癌细胞迁移及侵袭的影响[J]. 实用肿瘤学杂志, 2019, 33(3): 222-227.
[9]	孟海,杜观祥,朱利玲,汤琪云. WEE1在胃癌组织中的表达及对患者预后的影响[J]. 实用肿瘤学杂志, 2019, 33(3): 239-243.
[10]	刘佳音,燕飞虎,张艳桥. 凋亡基因Caspase3和Caspase7单核苷酸多态性与胃癌遗传易感性研究[J]. 实用肿瘤学杂志, 2019, 33(3): 250-255.
[11]	白玉贤, 马仲娟, 苏颖玲, 慕安国, 谢蕊. 胃癌患者FHIT、hMLH1、p16、RAR-beta、Reprimo和TIMP3基因的甲基化研究[J]. 实用肿瘤学杂志, 2019, 33(1): 8-13.
[12]	张凤春, 江莺, 刘照南, 闫宁宁, 崔洪全, 徐迎春. 系统性炎症相关指标中性粒细胞/淋巴细胞比值及血小板/淋巴细胞比值在根治性切除术后的胃癌患者的预后意义[J]. 实用肿瘤学杂志, 2019, 33(1): 34-39.
[13]	张宝综述, 郑志超校审. 进展期胃癌淋巴结清扫研究进展[J]. 实用肿瘤学杂志, 2019, 33(1): 78-81.
[14]	唐淑丽, 何匡邦, 张纯慧, 程佳楠, 张艳桥. 胃癌组织中miR-320a和CYLD的表达及与临床病理特征及预后的关系[J]. 实用肿瘤学杂志, 2018, 32(6): 538-544.
[15]	迪娜·木拉力, 胡昕综述, 加孜那·托哈依审校. 远程医疗在肺癌中的应用及前景[J]. 实用肿瘤学杂志, 2018, 32(6): 555-557.